Literature DB >> 32081252

The Complex Role of Nociceptin Signaling in Stress: Clarity Through Neuroimaging?

Sean C Piantadosi1, Diego A Pizzagalli2, Michael R Bruchas3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32081252      PMCID： PMC7875195          DOI： 10.1016/j.biopsych.2020.01.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   12.810


× No keyword cloud information.
  10 in total

1.  Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors.

Authors:  Roberto Ciccocioppo; Giordano de Guglielmo; Anita C Hansson; Massimo Ubaldi; Marsida Kallupi; Maureen T Cruz; Christopher S Oleata; Markus Heilig; Marisa Roberto
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

2.  A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward.

Authors:  Kyle E Parker; Christian E Pedersen; Adrian M Gomez; Skylar M Spangler; Marie C Walicki; Shelley Y Feng; Sarah L Stewart; James M Otis; Ream Al-Hasani; Jordan G McCall; Kristina Sakers; Dionnet L Bhatti; Bryan A Copits; Robert W Gereau; Thomas Jhou; Thomas J Kash; Joseph D Dougherty; Garret D Stuber; Michael R Bruchas
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

3.  Decreased Nociceptin Receptors Are Related to Resilience and Recovery in College Women Who Have Experienced Sexual Violence: Therapeutic Implications for Posttraumatic Stress Disorder.

Authors:  Rajesh Narendran; Savannah Tollefson; Kelli Fasenmyer; Jennifer Paris; Michael L Himes; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Biol Psychiatry       Date:  2019-04-04       Impact factor: 13.382

4.  Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.

Authors:  Victor W Pike; Karen S Rash; Zhaogen Chen; Concepción Pedregal; Michael A Statnick; Yasuyuki Kimura; Jinsoo Hong; Sami S Zoghbi; Masahiro Fujita; Miguel A Toledo; Nuria Diaz; Susan L Gackenheimer; Johannes T Tauscher; Vanessa N Barth; Robert B Innis
Journal:  J Med Chem       Date:  2011-03-25       Impact factor: 7.446

5.  Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis.

Authors:  Donata Rodi; Silvia Zucchini; Michele Simonato; Carlo Cifani; Maurizio Massi; Carlo Polidori
Journal:  Psychopharmacology (Berl)       Date:  2007-11-07       Impact factor: 4.530

6.  Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress.

Authors:  D P Devine; M T Hoversten; Y Ueda; H Akil
Journal:  J Neuroendocrinol       Date:  2003-01       Impact factor: 3.627

Review 7.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 8.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

Review 9.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

Authors:  Jeffrey M Witkin; Michael A Statnick; Linda M Rorick-Kehn; John E Pintar; Michael Ansonoff; Yanyun Chen; R Craig Tucker; Roberto Ciccocioppo
Journal:  Pharmacol Ther       Date:  2013-11-01       Impact factor: 12.310

10.  Acute Elevations in Cortisol Increase the In Vivo Binding of [11C]NOP-1A to Nociceptin Receptors: A Novel Imaging Paradigm to Study the Interaction Between Stress- and Antistress-Regulating Neuropeptides.

Authors:  Margaret Flanigan; Savannah Tollefson; Michael L Himes; Rehima Jordan; Katherine Roach; Clara Stoughton; Brian Lopresti; N Scott Mason; Roberto Ciccocioppo; Rajesh Narendran
Journal:  Biol Psychiatry       Date:  2019-09-25       Impact factor: 12.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.